Uwe Haberkorn

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

K. Jöckel, A. Hüttmann, L. Geworski, 2018, Journal of Clinical Oncology.

Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.

W. J. Lorenz, L. Strauss, G. Brix, 1997, Cancer research.

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.

G Brix, J Zaers, H Ostertag, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

G. van Kaick, U. Haberkorn, G. Kaick, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.

G. van Kaick, L. Strauss, U. Haberkorn, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

G. van Kaick, L. Strauss, U. Haberkorn, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.